Nagaraju Kerru

4.4k total citations · 1 hit paper
86 papers, 3.6k citations indexed

About

Nagaraju Kerru is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Nagaraju Kerru has authored 86 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Organic Chemistry, 8 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Nagaraju Kerru's work include Multicomponent Synthesis of Heterocycles (54 papers), Synthesis and biological activity (51 papers) and Chemical Synthesis and Reactions (17 papers). Nagaraju Kerru is often cited by papers focused on Multicomponent Synthesis of Heterocycles (54 papers), Synthesis and biological activity (51 papers) and Chemical Synthesis and Reactions (17 papers). Nagaraju Kerru collaborates with scholars based in South Africa, India and United States. Nagaraju Kerru's co-authors include Sreekantha B. Jonnalagadda, Suresh Maddila, Lalitha Gummidi, Kranthi Kumar Gangu, Parvesh Singh, Paul Awolade, Surya Narayana Maddila, Ashona Singh‐Pillay, Sandeep V. H. S. Bhaskaruni and C. Venkata Rao and has published in prestigious journals such as Scientific Reports, Molecules and RSC Advances.

In The Last Decade

Nagaraju Kerru

81 papers receiving 3.5k citations

Hit Papers

A Review on Recent Advances in Nitrogen-Containing Molecu... 2020 2026 2022 2024 2020 250 500 750 1000

Peers

Nagaraju Kerru
Nagaraju Kerru
Citations per year, relative to Nagaraju Kerru Nagaraju Kerru (= 1×) peers Abdullah Mohammed Al‐Majid

Countries citing papers authored by Nagaraju Kerru

Since Specialization
Citations

This map shows the geographic impact of Nagaraju Kerru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nagaraju Kerru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nagaraju Kerru more than expected).

Fields of papers citing papers by Nagaraju Kerru

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nagaraju Kerru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nagaraju Kerru. The network helps show where Nagaraju Kerru may publish in the future.

Co-authorship network of co-authors of Nagaraju Kerru

This figure shows the co-authorship network connecting the top 25 collaborators of Nagaraju Kerru. A scholar is included among the top collaborators of Nagaraju Kerru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nagaraju Kerru. Nagaraju Kerru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chinnam, Sampath, Guddekoppa S. Ananthnag, Kumarappan Chidambaram, et al.. (2025). Design, synthesis, crystal structure of novel hydrazone analogues as SARS-CoV-2 potent inhibitors: MD simulations, MM-GBSA, docking and ADMET studies. Royal Society Open Science. 12(7). 1 indexed citations
2.
Kerru, Nagaraju, et al.. (2025). Design Strategy and Synthesis of Novel Pyrazole-Linked 1,3,4-Oxadiazole Hybrids as Potent Anti-Tubercular Agents. Polycyclic aromatic compounds. 45(10). 2141–2151.
3.
Mishra, Sahil, Nagaraju Kerru, Françoise Roquet‐Banères, et al.. (2025). Isoniazid‐Dihydropyrimidinone Molecular Hybrids: Design, Synthesis, Antitubercular Activity, and Cytotoxicity Investigations with Computational Validation. ChemMedChem. 20(11). e202400949–e202400949. 1 indexed citations
4.
Kerru, Nagaraju, et al.. (2025). Molecular design, synthesis and antimicrobial evaluation of quinoline-based oxadiazole hybrids as potential inhibitors of DNA gyrase. Journal of Molecular Structure. 1349. 143829–143829.
7.
Gangu, Kranthi Kumar, et al.. (2023). Synthesis of a novel chloroquinoline, rhodanine encompassed 1,2,3-triazole scaffolds and molecular docking evaluation of their cytotoxicity. Journal of the Iranian Chemical Society. 20(10). 2643–2655. 16 indexed citations
8.
Kerru, Nagaraju, et al.. (2020). A green, efficient protocol for the catalyst-free synthesis of tetrahydro-1H-pyrazolo-[3,4-b]-quinolin-5(4H)-ones supported by ultrasonicirradiation. Chemical Data Collections. 30. 100566–100566. 16 indexed citations
9.
Maddila, Suresh, Nagaraju Kerru, & Sreekantha B. Jonnalagadda. (2020). Synthesis and antimicrobial evaluation of novel pyrano[2,3-d]-pyrimidine bearing 1,2,3-triazoles. Chemical Data Collections. 28. 100486–100486. 48 indexed citations
10.
Gummidi, Lalitha, Nagaraju Kerru, Paul Awolade, et al.. (2020). Synthesis of indole-tethered [1,3,4]thiadiazolo and [1,3,4]oxadiazolo[3,2-a]pyrimidin-5-one hybrids as anti-pancreatic cancer agents. Bioorganic & Medicinal Chemistry Letters. 30(22). 127544–127544. 12 indexed citations
11.
Gummidi, Lalitha, Nagaraju Kerru, Paul Awolade, et al.. (2020). N-Phenyl substituent controlled diastereoselective synthesis of β-lactam-isatin conjugates. Tetrahedron Letters. 61(11). 151602–151602. 4 indexed citations
12.
Kerru, Nagaraju, Lalitha Gummidi, Suresh Maddila, & Sreekantha B. Jonnalagadda. (2020). Efficient synthesis of novel functionalized dihydro‑pyrazolo[3,4-d]pyridines via the three-component reaction using MgO/HAp as a sustainable catalyst. Inorganic Chemistry Communications. 123. 108321–108321. 22 indexed citations
13.
Awolade, Paul, Nosipho Cele, Nagaraju Kerru, & Parvesh Singh. (2020). Synthesis, antimicrobial evaluation, and in silico studies of quinoline—1H-1,2,3-triazole molecular hybrids. Molecular Diversity. 25(4). 2201–2218. 51 indexed citations
14.
Kerru, Nagaraju, Sandeep V. H. S. Bhaskaruni, Lalitha Gummidi, et al.. (2019). Recent advances in heterogeneous catalysts for the synthesis of imidazole derivatives. Synthetic Communications. 49(19). 2437–2459. 87 indexed citations
15.
Awolade, Paul, Nosipho Cele, Nagaraju Kerru, et al.. (2019). Therapeutic significance of β-glucuronidase activity and its inhibitors: A review. European Journal of Medicinal Chemistry. 187. 111921–111921. 115 indexed citations
17.
Kerru, Nagaraju, Lalitha Gummidi, Sandeep V. H. S. Bhaskaruni, Surya Narayana Maddila, & Sreekantha B. Jonnalagadda. (2019). Green synthesis and characterization of novel 1,2,4,5-tetrasubstituted imidazole derivatives with eco-friendly red brick clay as efficacious catalyst. Molecular Diversity. 24(4). 889–901. 19 indexed citations
18.
Dhawan, Sanjeev, Nagaraju Kerru, Paul Awolade, et al.. (2018). Synthesis, computational studies and antiproliferative activities of coumarin-tagged 1,3,4-oxadiazole conjugates against MDA-MB-231 and MCF-7 human breast cancer cells. Bioorganic & Medicinal Chemistry. 26(21). 5612–5623. 53 indexed citations
19.
Kerru, Nagaraju, Ashona Singh‐Pillay, Paul Awolade, & Parvesh Singh. (2018). Current anti-diabetic agents and their molecular targets: A review. European Journal of Medicinal Chemistry. 152. 436–488. 292 indexed citations
20.
Yalagala, Kotaiah, et al.. (2014). Synthesis, docking and evaluation of antioxidant and antimicrobial activities of novel 1,2,4-triazolo[3,4-b][1,3,4]thiadiazol-6-yl)selenopheno[2,3-d]pyrimidines. European Journal of Medicinal Chemistry. 75. 195–202. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026